Long-term effectiveness and side-effects of intranasal esketamine in treatment-resistant depression: real-world, single-arm study of over 100 sessions. [PDF]
BJPsych OpenAyad N +4 more
europepmc +1 more source
ED95 of Ciprofol Combined with Esketamine or Sufentanil in Elderly Patients Undergoing Endoscopic Submucosal Dissection: A Dose-Finding and Randomized Controlled Trial. [PDF]
Drug Des Devel TherQin X +5 more
europepmc +1 more source
Comparative Effectiveness of Single-Dose Epidural Esketamine versus Hydromorphone in Thoracic and Upper Abdominal Surgery: A Randomized Trial. [PDF]
Drug Des Devel TherSong Y +8 more
europepmc +1 more source
Effect of esketamine-based patient-controlled intravenous analgesia on postoperative pain and quality of recovery after video-assisted thoracoscopic lobectomy: A prospective, double-blind, randomized controlled trial. [PDF]
PLoS OneBi R +6 more
europepmc +1 more source
Esketamine Enhances the Chemosensitivity of Colorectal Adenocarcinoma Cells to 5-Fluorouracil via AMPK/mTOR/HMMR Signaling Pathway. [PDF]
Oncol ResFeng Y +6 more
europepmc +1 more source
Related searches:
Esketamine for treatment resistant depression
BMJ, 2019Introduction: Treatment Resistant Depression (TRD) is a common and burdensome condition with poor outcomes and few treatment options. Esketamine is the S-enantiomer of ketamine and has recently been FDA approved in the United States for treating depression that has failed to respond to trials of two or more antidepressants.
Sameer, Jauhar, Paul, Morrison
exaly +6 more sources
Depression is more than feeling a little sad or "blue" for a few days. Antidepressant medications are used in the treatment of clinical depression, usually alongside other forms of therapy such as psychological or behavioral therapy. Spravato is a medicine used to treat adults with major depression that is resistant to treatment.
Nirosha V., Gayathri V.
openaire +1 more source